AstraZeneca's China chief in custody, believes unrelated to insurance probe
AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not know the reason, it did not believe it was linked to a large health insurance fraud case involving the company.
AstraZeneca’s Stock Price Takes a Hit as China Chief Investigated for Insurance Fraud
BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” to AstraZeneca, but contends that the share selloff is “overdone” and likely a knee-jerk reaction by investors.
AstraZeneca Falls Most Since 2020 as China Probe Fears Mount
AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns over a Chinese probe into the UK drugmaker.
AstraZeneca: China's investigation into exec separate from medical insurance probe
AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top executive in the country, Leon Wang, is separate from a large health insurance fraud case also involving the company.
Top AstraZeneca Executives Caught in Expanding China Probe, Shares Slide Further
AstraZeneca stock tumbles as Chinese probe widens, implicating executives in insurance fraud and drug import violations
AstraZeneca Says Current, Former Executives Involved in China Probe
AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior executives at its China unit could be implicated in the largest insurance fraud case in the country's pharma sector in years.
Yicai Global2h
US Food and Agriculture Pavilion Signs USD815 Million of Deals on First Day of Opening at CIIE
(Yicai) Nov. 7 -- The American Food and Agricultural Pavilion penned contracts worth USD815 million on its opening day at the 7th China International Import Expo yesterday, a 65 percent jump from last ...
STAT18h
AstraZeneca falls on reports of Chinese probe
Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...
FiercePharma1d
UPDATED: AstraZeneca stock tanks over fears of expanding China fraud probe
AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...
Chinese authorities probing ‘dozens’ of AstraZeneca executives, Yicai reports
Chinese authorities are investigating dozens of senior AstraZeneca (AZN) China executives amid an ongoing insurance fraud case, Yicai Global ...
Yicai Global14h
China Sales Decline for Top Car Multinationals as Local EV Brands Thrive
Foreign carmakers are losing ground in the world's biggest auto market. As the Chinese market for combustion engine vehicles shrinks, local automakers such as BYD, Geely Holding Group, and Li Auto ...
AstraZeneca extends losses as Chinese probe widens
AstraZeneca (NASDAQ:AZN) continued to trade lower on Wednesday amid reports that an ongoing probe linked to illegal drug importations and data privacy concerns implicated two current and two former ...
pharmaphorum1d
AZ shares weaken as China investigation rumours swirl
AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest ...